Joseph Eichenbaum
Cardiology · Lynbrook, NYNPI 1053301267
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Merck at 26.7% of the total. 2025 is the largest year on record at $585, 3.9 times the $149 reported in 2019.
Across 112 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$594
- Novartis$506
- Amgen$389
- Johnson & Johnson$251
- AstraZeneca$146
- E.r. Squibb & Sons, L.L.C.$145
- plus $193 from 6 others
What the payments were for
- Food & beverage$2,224100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 27 | $594 |
| Novartis | 33 | $506 |
| Amgen | 16 | $389 |
| Johnson & Johnson | 12 | $251 |
| AstraZeneca | 8 | $146 |
| E.r. Squibb & Sons, L.L.C. | 7 | $145 |
| Pfizer | 3 | $57 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Boston Scientific | 1 | $30 |
| Bayer | 1 | $27 |
| Novo Nordisk | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
How this compares
$2,224 in reported general payments places this provider in the 70th percentile of 112 cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 222 | $279,334 |
| XareltoRivaroxaban | 134 | $198,585 |
| EntrestoSacubitril/Valsartan | 116 | $118,280 |
| BrilintaTicagrelor | 50 | $55,806 |
| FarxigaDapagliflozin Propanediol | 34 | $53,116 |
| Repatha SureclickEvolocumab | 34 | $33,968 |
| JardianceEmpagliflozin | 16 | $24,127 |
| VerquvoVericiguat | 12 | $14,306 |
| Metoprolol Succinate | 434 | $7,319 |
| Ranolazine ErRanolazine | 13 | $5,738 |
| Rosuvastatin Calcium | 341 | $5,420 |
| Losartan Potassium | 466 | $5,037 |
| Amlodipine Besylate | 538 | $4,266 |
| Ezetimibe | 112 | $3,997 |
| Atorvastatin Calcium | 360 | $3,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $57 | $279,334222 claims |
| Johnson & JohnsonXarelto | $251 | $198,585134 claims |
| NovartisEntresto | $506 | $118,280116 claims |
| AstraZenecaBrilinta, Farxiga | $146 | $108,92384 claims |
| MerckVerquvo | $594 | $14,30612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 112 cardiology providers in New York.
Other cardiology in Lynbrook
- Mohammed MuneeruddinLynbrook$5K
- David WeinstockLynbrook$2K
- Felix OviasuGarden City$150K
- David D'agateSmithtown$69K
- Michael SiegalNew York$43K
- Michael AvaricioOzone Park$41K
- Bimalkumar BrahmbhattAmityville$31K
- Michael HappesSmithtown$30K
- Meyer AbittanRoslyn$28K
- Perminder GrewalStony Point$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.